GnT-V, macrophage and cancer metastasis: a common link.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 12856724)

Published in Clin Exp Metastasis on January 01, 2003

Authors

A K Chakraborty1, J M Pawelek

Author Affiliations

1: Yale University School of Medicine, Department of Dermatology, 333 Cedar Street, New Haven, Connecticut 06520, USA. ashok.chakraborty@yale.edu

Articles cited by this

(truncated to the top 100)

Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06

New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71

Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell (1991) 9.73

Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol (1989) 6.55

Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (1980) 5.84

Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell (1990) 5.15

The origin and function of tumor-associated macrophages. Immunol Today (1992) 5.12

The matrix-degrading metalloproteinases. Bioessays (1992) 4.84

Phagocyte recognition of cells undergoing apoptosis. Immunol Today (1993) 4.77

Glycobiology. Annu Rev Biochem (1988) 4.51

ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science (1990) 4.45

Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol (1995) 4.26

Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol (1989) 3.77

Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science (1990) 3.74

Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res (1996) 3.73

A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell (1989) 3.34

Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res (1989) 3.25

Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta (1999) 3.17

Changes in integrin receptors on oncogenically transformed cells. Cell (1989) 3.09

Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07

Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem (1991) 3.01

ELAM-1--dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell (1990) 2.97

Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science (1987) 2.86

Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med (2000) 2.61

Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes. J Immunol (1975) 2.58

Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest (1993) 2.45

Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J Biol Chem (1982) 2.43

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer (2002) 2.39

Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res (1991) 2.36

Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest (1991) 2.32

Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene (2002) 2.31

Molecular aspects of tumor cell invasion and metastasis. Cancer (1993) 2.24

Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A (1992) 2.18

Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02

Integrins and tumor cell dissemination. Cancer Cells (1989) 1.93

Possible roles of tumor-associated carbohydrate antigens. Cancer Res (1996) 1.90

Matrix metalloproteinases in human melanoma. J Invest Dermatol (2000) 1.84

Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol (1990) 1.82

Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion. Curr Opin Cell Biol (2000) 1.82

The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia (2002) 1.72

The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer (2000) 1.71

Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem (1992) 1.71

Structure of sialylated fucosyl lactosaminoglycan isolated from human granulocytes. J Biol Chem (1984) 1.65

Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev (1992) 1.58

Are advanced malignant melanoma cells hybrids between melanocytes and macrophages? Melanoma Res (1992) 1.54

Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A (1994) 1.50

Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature (1982) 1.48

Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci U S A (1995) 1.44

Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. EMBO J (1999) 1.42

Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res (1997) 1.42

Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. Biochim Biophys Acta (1985) 1.40

Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta (1988) 1.36

Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. J Biol Chem (1991) 1.36

Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res (1997) 1.34

Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetraantennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J Biol Chem (1986) 1.34

Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. J Biol Chem (1994) 1.32

Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol (1995) 1.31

Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J Biol Chem (2002) 1.30

Alphav integrins mediate adhesion and migration of breast carcinoma cell lines. Clin Exp Metastasis (1998) 1.29

Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis (1998) 1.23

Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J Biol Chem (1984) 1.21

Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J Biol Chem (1985) 1.19

Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res (1993) 1.19

Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Clin Cancer Res (1997) 1.17

A mouse lymphoma cell line resistant to the leukoagglutinating lectin from Phaseolus vulgaris is deficient in UDP-GlcNAc: alpha-D-mannoside beta 1,6 N-acetylglucosaminyltransferase. J Biol Chem (1982) 1.16

Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNAc:N-acetyllactosaminide beta 1----3-N-acetylglucosaminyltransferase from Novikoff tumor cell ascites fluid. J Biol Chem (1988) 1.16

Multiple roles of integrins in cell motility. Exp Cell Res (2000) 1.14

E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J Biol Chem (1993) 1.12

Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res (1986) 1.12

Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J Biol Chem (1997) 1.12

A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res (2000) 1.11

The macrophage content of some human tumours. Cancer Lett (1975) 1.10

Human osteosarcoma cells resistant to detachment by an Arg-Gly-Asp-containing peptide overproduce the fibronectin receptor. J Cell Biol (1987) 1.10

Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta (1999) 1.09

The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis (2002) 1.09

Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Oncogene (1989) 1.07

The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res (1993) 1.06

Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res (2001) 1.05

Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology (1994) 1.04

Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res (2000) 1.03

Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Cancer Res (1992) 1.02

Invasiveness of T-cell hybridomas in vitro and their metastatic potential in vivo. Cancer Res (1985) 1.02

Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res (1986) 1.01

Integrins as mediators of epithelial cell-matrix interactions in the human small intestinal mucosa. Microsc Res Tech (2000) 1.00

Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion. Clin Exp Metastasis (2002) 0.97

cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V+. Biochem Biophys Res Commun (1994) 0.96

Expression of the VLA beta 1 integrin family in bladder cancer. Am J Pathol (1994) 0.96

Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction. Cancer Res (1995) 0.96

Evidence that beta 1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes. Int J Cancer (1989) 0.96

Formation of multinucleated giant cells in vitro is dependent on the stage of monocyte to macrophage maturation. Blood (1997) 0.95

L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion. Arch Biochem Biophys (1993) 0.95

Glycosyltransferase assays using pyridylaminated acceptors: N-acetylglucosaminyltransferase III, IV, and V. Methods Enzymol (1989) 0.94

Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer (1994) 0.94

Functionally distinct roles for glycosylation of alpha and beta integrin chains in cell-matrix interactions. Proc Natl Acad Sci U S A (1993) 0.94

Metalloproteinases and cancer invasion and metastasis. Int J Cancer (1989) 0.94

Expression of alpha-(1,3)-fucosyltransferases which synthesize sialyl Le(x) and sialyl Le(a), the carbohydrate ligands for E- and P-selectins,in human malignant cell lines. Cancer Res (1993) 0.94

Glycosylation-dependent collagen-binding activities of two membrane glycoproteins in MDAY-D2 tumor cells. Cancer Res (1988) 0.93

Human monocyte x mouse melanoma fusion hybrids express human gene. Gene (2001) 0.93

Regulation of matrix metalloproteinases - their role in tumor invasion and metastasis. Int J Oncol (1993) 0.93

Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis. Cell Growth Differ (2001) 0.93

Articles by these authors

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol (1999) 3.97

Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta (1996) 1.39

5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature (1978) 1.31

Polymerization of 5,6-dihydroxyindole-2-carboxylic acid to melanin by the pmel 17/silver locus protein. Eur J Biochem (1996) 1.31

Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol (1976) 1.23

A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res (2000) 1.11

UV light and MSH receptors. Ann N Y Acad Sci (1999) 1.09

High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex. J Invest Dermatol (1994) 1.06

New regulators of melanogenesis are associated with purified tyrosinase isozymes. J Invest Dermatol (1982) 1.05

Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium. Invest Ophthalmol Vis Sci (1978) 1.03

The biosynthesis of mammalian melanin. Am Sci (1982) 1.03

New regulatory factors for melanogenesis: developmental changes in neonatal mice of various genotypes. Dev Biol (1983) 0.99

Evidence that dopachrome tautomerase is a ferrous iron-binding glycoprotein. FEBS Lett (1992) 0.97

Effects of thyroxine and low oxygen tension on chondrogenic expression in cell culture. Dev Biol (1969) 0.97

Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa. Cancer Res (1986) 0.96

Human monocyte x mouse melanoma fusion hybrids express human gene. Gene (2001) 0.93

Biology of hypopigmentation. J Am Acad Dermatol (1988) 0.89

Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J Invest Dermatol (1999) 0.88

Studies on the Cloudman melanoma cell line as a model for the action of MSH. Yale J Biol Med (1986) 0.87

Evidence suggesting that a cyclic AMP-dependent protein kinase is a positive regulator of proliferation in Cloudman S91 melanoma cells. J Cell Physiol (1979) 0.86

Membrane glycoproteins common to vesicles and melanosomes in mouse melanoma cells. Pigment Cell Res (1992) 0.86

Hairless pigmented guinea pigs: a new model for the study of mammalian pigmentation. Pigment Cell Res (1990) 0.86

Receptors for B-melanocyte-stimulating hormone exhibit positive cooperativity in synchronized melanoma cells. Biochemistry (1988) 0.85

Synthesis and characterization of melanins from dihydroxyindole-2-carboxylic acid and dihydroxyindole. Pigment Cell Res (1992) 0.82

Structural/functional relationships between internal and external MSH receptors: modulation of expression in Cloudman melanoma cells by UVB radiation. J Cell Physiol (1991) 0.82

Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine. Br J Dermatol (1995) 0.81

Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells. Biochem Biophys Res Commun (1987) 0.81

Is human melanogenesis stimulated by cyclic AMP? J Invest Dermatol (1990) 0.80

What controls melanogenesis? Exp Dermatol (1998) 0.79

Up-regulation of MSH receptors by MSH in Cloudman melanoma cells. Biochem Biophys Res Commun (1992) 0.78

Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: altered N-glycosylation as an underlying mechanism. Pigment Cell Res (1998) 0.78

Proopiomelanocortin in skin: new possibilities for regulation of skin physiology. J Lab Clin Med (1993) 0.77

A new enzyme in the pigment pathway? J Invest Dermatol (1985) 0.77

Phosphorylated mixed isomers of L-dopa increase melanin content in skins of Skh-2 pigmented hairless mice. Pigment Cell Res (1987) 0.77

Internal binding sites for MSH: analyses in wild-type and variant Cloudman melanoma cells. J Cell Physiol (1990) 0.76

Melanoma as a macrophage/melanocyte hybrid and the symbiotic nature of eukaryotic cells. Melanoma Res (1993) 0.76

Stimulation of the receptor for melanocyte-stimulating hormone by retinoic acid. FEBS Lett (1990) 0.76

Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol (1990) 0.76

Evidence that a 90-kDa phosphoprotein, an associated kinase, and a specific phosphatase are involved in the regulation of Cloudman melanoma cell proliferation by insulin. Proc Natl Acad Sci U S A (1985) 0.75

Effects of ultraviolet irradiation on the cell cycle. Pigment Cell Res (1994) 0.75

Tumor-Targeted Salmonella: Strain Development and Expression of the HSV-tK Effector Gene. Methods Mol Med (2000) 0.75

Inhibition of induced melanogenesis in Cloudman melanoma cells by four phenotypic modifiers. Exp Cell Res (1990) 0.75